In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | -100% |
2019 | $7.07 M | 109.22% |
2018 | $3.38 M | -20.96% |
2017 | $4.28 M | 87.09% |
2016 | $2.28 M | -30.24% |
2015 | $3.27 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | N/A | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | N/A | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | N/A | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | N/A | Jersey |